Mechanisms underlying mustard gas-induced conjunctival injury and use of lipid mediators as medical countermeasures
芥子气引起的结膜损伤的机制以及脂质介质作为医疗对策的使用
基本信息
- 批准号:10882060
- 负责人:
- 金额:$ 58.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAddressArchitectureBiological AssayCASP1 geneCell Culture TechniquesCell DensityCell physiologyCell surfaceChronicClinical ManagementClinical assessmentsCoculture TechniquesConjunctival EpitheliumConjunctivitisCorneaDendritic CellsEnzyme-Linked Immunosorbent AssayEpithelial CellsExposure toEyeEye InjuriesFlow CytometryFluoresceinGoblet CellsHistologicHistopathologyHomeostasisHumanImmuneIn VitroInflammasomeInflammationInflammatoryInflammatory ResponseInjectionsInjuryInnate Immune ResponseInterleukin-1 betaInterleukin-6LipidsLymphocytic InfiltrateMUC5AC geneMaintenanceMeasurementMeasuresMechlorethamineMediatingMediatorMedicalMethodsMolecularMucinsMucous MembraneMusMustard GasNeuropeptidesNociceptorsPathologyPhotophobiaPropertyProteinsRegulationRegulatory T-LymphocyteReportingResolutionReverse Transcriptase Polymerase Chain ReactionSecretory CellSecuritySeriesShapesSignal TransductionSigns and SymptomsSiteSmall Interfering RNASourceStainsStimulusStructure of trigeminal ganglionSymptomsTherapeuticThrombospondin 1TissuesTopical applicationToxic ActionsToxic effectTranscriptTransforming Growth Factor betaTreatment EfficacyVesicantsWestern Blottingacute symptomadaptive immune responsecell injuryconjunctivaeye drynessimmunoregulationin vivoinhibitorinsightlipid mediatorlipoxin A4medical countermeasuremouse modelnerve supplynovelnovel strategiesocular painocular surfacepharmacologicpreventresponserestorationretinal toxicityslit lamp imagingtherapeutic targetvascular abnormality
项目摘要
PROJECT SUMMARY
Mustard gas (MG, most commonly sulfur and nitrogen mustard) is a highly toxic vesicant that causes ocular
injuries in over 90% of exposed victims with symptoms lasting from minutes to years. These symptoms include
conjunctivitis in addition to eye pain, photophobia and corneal epitheliopathy. Moderate to severe exposure to
MG results in chronic or latent (delayed-onset) forms of symptoms that include changes in the conjunctiva such
as vascular abnormalities and histopathology including reduced goblet cell (GC) density and lymphocytic
infiltration. However, mechanisms of toxicity and therapeutic targets in the conjunctiva remain largely unknown.
We reported that in addition to protective soluble mucin, MUC5AC,GCs are a source of pro-inflammatory IL-1β
as well as immunomodulatory TGFβ and therefore play a role in shaping both local innate and adaptive
immune responses. The contribution of GC secretory products to ocular mucosal homeostasis is further
underscored by the observed chronic inflammation and related epitheliopathy associated with loss of GCs or
GC-derived regulatory factors. Specialized pro-resolving mediators (SPM) like D-series resolvins RvD1 are
endogenous lipid derivatives produced during inflammation are known to accelerate its resolution and
restoration of tissue architecture. We reported that RvD1 can inhibit secretion of GC-derived IL-1β. In this
proposal we will identify mechanisms underlying MG toxicity in the conjunctiva and its contribution to chronic
pathology. We will determine if SPMs restore homeostasis in the conjunctiva to prevent chronic damage
caused by MG and serve as effective medical counter measure (MCM) for ocular toxicity of MG. We
hypothesize that SPMs promote resolution of MG-induced ocular damage by modulating secretory and
homeostatic function of conjunctival GCs. To address this hypothesis, the following three specific aims are
proposed. Aim 1: Identify nitrogen mustard (NM)-induced alteration in conjunctival epithelial GC function and
the potential of SPMs to resolve NM toxicity and restore GC function in vitro; Aim 2: Determine if NM exposure
disrupts immune homeostatic function of GCs in vitro and if SPMs can restore it; and Aim3: Determine
therapeutic efficacy of RvD1 as a MCM, in vivo, using a mouse model of NM toxicity. Conjunctival and corneal
damage as well as ocular surface innervation will be evaluated. Our anticipated results from these studies can
reveal the potential of conjunctival GCs as a MG injury site and therefore a therapeutic target and provide
critical insights into developing novel strategies to promote mucosal and immune homeostasis in clinical
management of MG-induced ocular toxicity.
项目摘要
芥子气(MG,最常见的是硫和氮芥子气)是一种高毒性的起泡剂,
超过90%的暴露受害者受伤,症状持续数分钟至数年。这些症状包括
结膜炎以及眼痛、畏光和角膜上皮病。中度至重度暴露于
MG导致慢性或潜伏(延迟发作)形式的症状,包括结膜变化,
血管异常和组织病理学,包括杯状细胞(GC)密度降低和淋巴细胞
浸润然而,结膜中的毒性机制和治疗靶点在很大程度上仍然未知。
我们报道了除了保护性的可溶性粘蛋白MUC 5AC,GC是促炎性IL-1β的来源,
以及免疫调节性TGFβ,因此在形成局部先天性和适应性
免疫反应。GC分泌产物对眼粘膜稳态的作用进一步被证实。
通过观察到的与GC损失相关的慢性炎症和相关上皮病变强调,或
GC衍生的调节因子。专门的促消退介质(SPM),如D系列消退素RvD 1,
已知在炎症期间产生的内源性脂质衍生物加速其消退,
组织结构的恢复。我们报道了RvD 1可以抑制GC源性IL-1β的分泌。在这
我们将确定结膜中MG毒性的潜在机制及其对慢性炎症的贡献。
病理我们将确定SPM是否能恢复结膜的稳态,以防止慢性损伤
为MG眼毒性的有效医学对策提供了新的思路。我们
假设SPM通过调节分泌和分泌来促进MG诱导眼损伤的消退,
结膜GC的稳态功能。为了解决这一假设,以下三个具体目标是:
提出了目的1:鉴定氮芥(NM)诱导的结膜上皮GC功能的改变,
SPM在体外消除NM毒性和恢复GC功能的潜力;目的2:确定NM暴露是否
在体外破坏GC的免疫稳态功能,以及SPM是否可以恢复它;以及Aim 3:确定
使用NM毒性的小鼠模型,在体内观察RvD 1作为MCM的治疗功效。结膜和角膜
将评价损伤以及眼表面神经支配。这些研究的预期结果可以
揭示了结膜GC作为MG损伤部位的潜力,因此是治疗靶点,并提供了
在临床中开发新策略以促进粘膜和免疫稳态的重要见解
MG诱导的眼毒性的管理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Darlene A Dartt其他文献
Darlene A Dartt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Darlene A Dartt', 18)}}的其他基金
Construction of Conjunctival Equivalents Using Molecular Deposition Techniques
使用分子沉积技术构建结膜等效物
- 批准号:
10338062 - 财政年份:2020
- 资助金额:
$ 58.33万 - 项目类别:
Construction of Conjunctival Equivalents Using Molecular Deposition Techniques
使用分子沉积技术构建结膜等效物
- 批准号:
10557095 - 财政年份:2020
- 资助金额:
$ 58.33万 - 项目类别:
Construction of Conjunctival Equivalents Using Molecular Deposition Techniques
使用分子沉积技术构建结膜等效物
- 批准号:
9884619 - 财政年份:2020
- 资助金额:
$ 58.33万 - 项目类别:
Construction of Conjunctival Equivalents Using Molecular Deposition Techniques
使用分子沉积技术构建结膜等效物
- 批准号:
10089447 - 财政年份:2020
- 资助金额:
$ 58.33万 - 项目类别:
Conjunctival Goblet Cell Mucin Secretion in Inflammation and Its Resolution
炎症中结膜杯状细胞粘蛋白的分泌及其解决
- 批准号:
9920424 - 财政年份:2019
- 资助金额:
$ 58.33万 - 项目类别:
Conjunctival Goblet Cell NLRP3 Inflammasome in Ocular Surface Bacterial Infection
眼表细菌感染中的结膜杯状细胞NLRP3炎症小体
- 批准号:
8461558 - 财政年份:2012
- 资助金额:
$ 58.33万 - 项目类别:
Conjunctival Goblet Cell NLRP3 Inflammasome in Ocular Surface Bacterial Infection
眼表细菌感染中的结膜杯状细胞NLRP3炎症小体
- 批准号:
8274619 - 财政年份:2012
- 资助金额:
$ 58.33万 - 项目类别:
Conjunctival Goblet Cell NLRP3 Inflammasome in Ocular Surface Bacterial Infection
眼表细菌感染中的结膜杯状细胞NLRP3炎症小体
- 批准号:
8663916 - 财政年份:2012
- 资助金额:
$ 58.33万 - 项目类别:
Lacrimal Gland Regeneration:Identification and Isolation of Progenitor Cells
泪腺再生:祖细胞的鉴定和分离
- 批准号:
7978066 - 财政年份:2010
- 资助金额:
$ 58.33万 - 项目类别:
Conjunctival Goblet Cell Mucin Secretion in Inflammation and Its Resolution
炎症中结膜杯状细胞粘蛋白的分泌及其解决
- 批准号:
8990960 - 财政年份:2009
- 资助金额:
$ 58.33万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 58.33万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 58.33万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 58.33万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 58.33万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 58.33万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 58.33万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 58.33万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 58.33万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 58.33万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 58.33万 - 项目类别:
Research Grant